Lennox-Gastaut Syndrome Dravet Syndrome
Demographic characteristics at baseline (n = 10 000)a
Age group, y 2–5 6–11 12–17 18–55 2–5 6–11 12–17 18–55
Proportion of patients, % (SE) 13 (0.03) 36 (0.07) 25 (0.05) 26 (0.05) 30 (0.06) 39 (0.08) 29 (0.06) 2 (0.00)
Mean weight, kg (SE) 17.9 (0.87) 28.7 (1.34) 51.4 (2.67) 59.7 (2.65) 18.2 (0.53) 30.5 (1.14) 55.0 (2.27) 49.3 (2.27)
Age group ≥2 years ≥2 years
Mean age, y (SE) 13.2 (2.63) 11.5 (2.30)
Health state allocation at baseline: No. of seizures per
3 months
≤55 drop seizures >55 drop seizures ≤12 convulsive seizures >12 convulsive seizures
Proportion of patients, % (SE) 38 (0.08) 62 (0.12) 50 (0.10) 50 (0.10)
Sub-health state allocation at baseline: No. of days without seizures per 3 months No. of days without drop seizures
per month (SE)
No. of days without convulsive seizures
per month (SE)
≤15 days >15 days ≤15 days >15 days ≤18 days >18 days ≤18 days >18 days
Proportion of patients, % (SE) 81 (0.16) 19 (0.04) 99 (0.20) 1 (0.00) 1 (0.00) 99 (0.20) 79 (0.16) 21 (0.04)
Resource use, %
ASM Value SE Lower bound Upper bound Value SE Lower bound Upper bound
Clobazam 100 0.20 100.00 100.00 100 0.20 100.00 100.00
Clonazepam 5 0.01 3.27 7.22 7 0.01 4.20 9.30
Levetiracetam 35 0.07 21.88 49.04 20 0.04 12.83 28.54
Rufinamide 28 0.06 17.79 39.71 5 0.01 3.16 6.98
Stiripentol 0 0.00 0.00 0.00 44 0.09 27.26 61.51
Topiramate 14 0.03 9.00 19.97 22 0.04 13.85 30.83
Valproate sodium 0 0.00 0.00 0.00 22 0.04 13.85 30.83
Valproic acid 24 0.05 15.36 34.22 64 0.13 37.46 86.69
Zonisamide 12 0.03 7.94 17.59 11 0.02 6.99 15.48
Cost of care and hours of care per weekb
Health state Age group of patients with LGS Health state Age group of patients with DS
2-17 y 18-55 y 2-17 y 18-55 y
Hours of family care per week (SE) (€14.95 [replacement cost] per hour) Seizure-free 34.0 (6.8) 6.8 (1.4) Seizure-free 30.9 (6.2) 6.2 (1.2)
≤55 seizures 67.5 (13.5) 13.5 (2.7) ≤12 seizures 61.3 (12.3) 12.3 (2.5)
>55 seizures 72.1 (14.4) 14.4 (2.9) >12 seizures 66.1 (13.2) 13.2 (2.6)
Hours of professional care per week (SE) (€53.40 per hour) Seizure-free 22.7 (4.5) 4.5 (0.9) Seizure-free 20.6 (4.1) 4.1 (0.8)
≤55 seizures 45.0 (9.0) 9.0 (1.8) ≤12 seizures 40.9 (8.2) 8.2 (1.6)
>55 seizures 48.1 (9.6) 9.6 (1.9) >12 seizures 44.1 (8.8) 8.8 (1.8)
Utility valuesc
No. of seizures per month No. of days without drop seizures
per month (SE)
No. of days without convulsive seizures
per month (SE)
≤15 days >15 days ≤18 days >18 days
Seizure-free N/A 0.754 (0.037) N/A 0.778 (0.023)
≤55 drop seizures (LGS);
≤12 convulsive seizures (DS)
0.375 (0.000) 0.565 (0.047) 0.000 (0.000) 0.690 (0.028)
>55 drop seizures (LGS);
>12 convulsive seizures (DS)
−0.037 (0.062) 0.153 (0.063) 0.267 (0.053) 0.437 (0.000)